TrianglePUBLICATIONS · 25538264
A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Clin Cancer Res
- Publication date
- 2015 Mar 1
- First author
- Robbins PF
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Robbins PF
- type
- Author
- name
- Kassim SH
- type
- Author
- name
- Tran TL
- type
- Author
- name
- Crystal JS
- type
- Author
- name
- Morgan RA
- type
- Author
- name
- Feldman SA
- type
- Author
- name
- Yang JC
- type
- Author
- name
- Dudley ME
- type
- Author
- name
- Wunderlich JR
- type
- Author
- name
- Sherry RM
- type
- Author
- name
- Kammula US
- type
- Author
- name
- Hughes MS
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Robbins PF
- type
- Author
- name
- Kassim SH
- type
- Author
- name
- Tran TL
- type
- Author
- name
- Crystal JS
- type
- Author
- name
- Morgan RA
- type
- Author
- name
- Feldman SA
- type
- Author
- name
- Yang JC
- type
- Author
- name
- Dudley ME
- type
- Author
- name
- Wunderlich JR
- type
- Author
- name
- Sherry RM
- type
- Author
- name
- Kammula US
- type
- Author
- name
- Hughes MS
- type
- Author
- bibliography ids
- nci-bib-5b366b074817e277e4efb29b
- book metadata
- content sha256
- 839e7dd60cfde58f6e6dc665515cdc7645d2a584ab0e19635291069ccf1738d5
- document type
- citation
- dois
- 10.1158/1078-0432.CCR-14-2708
- electronic publication date
- display
- 2014 Dec 23
- precision
- day
- year
- 2014
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:25538264
- immutable id
- pubmed:25538264@839e7dd60cfde58f6e6dc665515cdc7645d2a584ab0e19635291069ccf1738d5
- journal
- abbreviation
- Clin Cancer Res
- issn electronic
- 1557-3265
- issn print
- 1078-0432
- issue
- 5
- name
- Clinical cancer research : an official journal of the American Association for Cancer Research
- nlm unique id
- 9502500
- pages
- 1019-27
- volume
- 21
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 25538264
- provenance
- batch id
- 863b068fe5a07222af6a
- provider
- NCBI PubMed ESummary
- record sha256
- 48e1ed49c982f295afc39d9ff8a2c400695dc1cd809c825034ab9956a6c1e28d
- response sha256
- 80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
- retrieved at
- 2026-09-09T23:47:07.648963+00:00
- publication date
- display
- 2015 Mar 1
- precision
- day
- year
- 2015
- publication types
- Clinical Trial
- Journal Article
- Research Support, N.I.H., Intramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response.
Preserved source evidence · Not medical advice